8:04 am Arena Pharm Announces Filing for Marketing Authorization of BELVIQ (lorcaserin HCl) in Brazil; Eisai’s (ESALY) Filing for Approval of BELVIQ as a Treatment for Chronic Weight Management Triggers
View todays social media effects on ARNA
View the latest stocks trending across Twitter. Click to view dashboard
See who Arena is hiring next, click here to view
